Prednisone is used for many different [[autoimmune disease]]s and inflammatory conditions, including: [[asthma]], [[COPD]], [[CIDP]], [[rheumatic disorders]], [[allergic]] disorders, [[ulcerative colitis]] and [[Crohn's disease]], [[adrenocortical insufficiency]], [[hypercalcemia]] due to cancer, [[thyroiditis]], [[laryngitis]], severe [[tuberculosis]], [[urticaria]] (hives), [[lipid pneumonitis]], [[pericarditis]], [[multiple sclerosis]], [[nephrotic syndrome]], [[sarcoidosis]], to relieve the effects of [[shingles]], [[lupus]], [[myasthenia gravis]], [[poison oak]] exposure, [[Ménière's disease]],  [[autoimmune hepatitis]], the [[Herxheimer reaction]] that is common during the treatment of [[syphilis]], [[Duchenne muscular dystrophy]], [[uveitis]], and as part of a drug regimen to prevent rejection after [[organ transplant]].<ref>{{EMedicine|article|172356|Autoimmune Hepatitis|treatment}}</ref><ref>{{Cite web|url=https://livertox.nlm.nih.gov//Corticosteroids.htm|title=Corticosteroids|website=livertox.nlm.nih.gov|access-date=2017-04-07}}</ref><ref name=AHFS>{{cite web|title=Prednisone|url=http://www.drugs.com/monograph/prednisone.html|work=The American Society of Health-System Pharmacists|accessdate=3 April 2011}}</ref>

 
Prednisone can be used in the treatment of decompensated [[heart failure]] to potentiate renal responsiveness to diuretics, especially in [[heart failure]] patients with refractory diuretic resistance with large dose of loop diuretics.<ref>{{cite journal|last=RIEMER|first=AD|title=Application of the newer corticosteroids to augment diuresis in congestive heart failure.|journal=The American journal of cardiology|date=April 1958|volume=1|issue=4|pages=488–96|pmid=13520608|doi=10.1016/0002-9149(58)90120-6}}</ref><ref>{{cite journal|last=NEWMAN|first=DA|title=Reversal of intractable cardiac edema with prednisone.|journal=New York state journal of medicine|date=15 February 1959|volume=59|issue=4|pages=625–33|pmid=13632954}}</ref><ref>{{cite journal|authors=Zhang, H; Liu, C; Ji, Z; Liu, G; Zhao, Q; Ao, YG; Wang, L; Deng, B; Zhen, Y; Tian, L; Ji, L; Liu, K|title=Prednisone adding to usual care treatment for refractory decompensated congestive heart failure.|journal=International heart journal|date=September 2008|volume=49|issue=5|pages=587–95|pmid=18971570|doi=10.1536/ihj.49.587}}</ref><ref>{{cite journal|last=Liu|first=C|author2=Liu, G |author3=Zhou, C |author4=Ji, Z |author5=Zhen, Y |author6= Liu, K |title=Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistance.|journal=The Canadian journal of cardiology|date=September 2007|volume=23|issue=11|pages=865–8|pmid=17876376|pmc=2651362 |doi=10.1016/s0828-282x(07)70840-1}}</ref><ref>{{cite journal|authors=Liu, C; Chen, H; Zhou, C; Ji, Z; Liu, G; Gao, Y; Tian, L; Yao, L; Zheng, Y; Zhao, Q; Liu, K|title=Potent potentiating diuretic effects of prednisone in congestive heart failure.|journal=Journal of cardiovascular pharmacology|date=October 2006|volume=48|issue=4|pages=173–6|pmid=17086096|doi=10.1097/01.fjc.0000245242.57088.5b}}</ref><ref>{{cite journal|last=Massari|first=F|author2=Mastropasqua, F |author3=Iacoviello, M |author4=Nuzzolese, V |author5=Torres, D |author6= Parrinello, G |title=The glucocorticoid in acute decompensated heart failure: Dr Jekyll or Mr Hyde?|journal=The American Journal of Emergency Medicine|date=March 2012|volume=30|issue=3|pages=517.e5–517.e10 |pmid=21406321|doi=10.1016/j.ajem.2011.01.023}}</ref> In terms of the mechanism of action for this purpose: prednisone, a [[glucocorticoid]], can improve renal responsiveness to atrial [[Natriuresis|natriuretic]] peptide by increasing the density of natriuretic peptide receptor type A in the renal inner medullary collecting duct, inducing a potent diuresis.<ref>{{cite journal|last=Liu|first=C|author2=Chen, Y |author3=Kang, Y |author4=Ni, Z |author5=Xiu, H |author6=Guan, J |author7= Liu, K |title=Glucocorticoids improve renal responsiveness to [[atrial natriuretic peptide]] by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.|journal=The Journal of Pharmacology and Experimental Therapeutics|date=October 2011|volume=339|issue=1|pages=203–9|pmid=21737535|doi=10.1124/jpet.111.184796}}</ref>

 
== Side effects ==

 
Short-term side effects, as with all glucocorticoids, include high blood [[glucose]] levels (especially in patients with [[diabetes mellitus]] or on other medications that increase blood glucose, such as [[tacrolimus]]) and [[mineralocorticoid]] effects such as fluid retention.<ref name=":0">{{Cite news|url=http://www.mayoclinic.org/steroids/art-20045692?pg=2|title=Prednisone and other corticosteroids: Balance the risks and benefits - Mayo Clinic|work=Mayo Clinic|access-date=2017-04-07|language=en}}</ref> The mineralocorticoid effects of prednisone are minor, which is why it is not used in the management of adrenal insufficiency, unless a more potent mineralocorticoid is administered concomitantly.

 
It can also cause [[Depression (mood)|depression]] or depressive symptoms and [[anxiety]] in some individuals.<ref>[http://www.drugs.com/prednisone.html Prednisone Information from Drugs.com<!-- Bot generated title -->]</ref><ref>[http://www.nlm.nih.gov/medlineplus/druginfo/meds/a601102.html#side-effects Prednisone: MedlinePlus Drug Information<!-- Bot generated title -->]</ref>

 
Long-term side effects include [[Cushing's syndrome]], [[steroid dementia syndrome]],<ref name="WolkowitzLupien2007">{{cite journal|last1=Wolkowitz|first1=Owen M.|last2=Lupien|first2=Sonia J.|last3=Bigler|first3=Erin D.|title=The "Steroid Dementia Syndrome": A Possible Model of Human Glucocorticoid Neurotoxicity|journal=Neurocase|volume=13|issue=3|year=2007|pages=189–200|issn=1355-4794|doi=10.1080/13554790701475468|pmid=17786779}}</ref> [[torso|truncal]] weight gain, [[osteoporosis]], [[glaucoma]] and [[cataracts]], diabetes mellitus [[Diabetes mellitus type 2|type 2]], and [[Depression (mood)|depression]] upon dose reduction or cessation.{{citation needed|date=December 2012}}

 
[[Adrenal gland|Adrenal]] suppression will begin to occur if prednisone is taken for longer than seven days.  Eventually, this may cause the body to temporarily lose the ability to manufacture natural corticosteroids (especially cortisol), which results in dependence on prednisone. For this reason, prednisone should not be abruptly stopped if taken for more than seven days; instead, the dosage should be gradually reduced. This weaning process may be over a few days, if the course of prednisone was short, but may take weeks or months {{Citation needed|date=November 2013}} if the patient had been on long-term treatment. Abrupt withdrawal may lead to an [[Addison's disease#Addisonian crisis|Addison crisis]]. For those on chronic therapy, alternate-day dosing may preserve adrenal function and thereby reduce side effects.<ref>{{cite web |url=https://web.archive.org/web/20080711145809/http://www.uspharmacist.com/NewLook/CE/glucocort/lesson.htm |title=Therapeutic and Adverse Effects of Glucocorticoids |work=Bello CS, Garrett SD. U.S. Pharmacist Continuing Education Program no. 430-000-99-028-H01, August 1999}}</ref>

 
Prednisone has no substantial biological effects until converted via hepatic metabolism to [[prednisolone]].<ref>[http://druginfo.nlm.nih.gov/drugportal/ProxyServlet?mergeData=true&objectHandle=DBMaint&APPLICATION_NAME=drugportal&actionHandle=default&nextPage=jsp/drugportal/ResultScreen.jsp&TXTSUPERLISTID=0000053032&QV1=PREDNISONE Medline drug information for prednisone]</ref>
